Anti-inflammatory Compound MgIG Eases COPD Symptoms in Rat Model

Anti-inflammatory Compound MgIG Eases COPD Symptoms in Rat Model

314367

Anti-inflammatory Compound MgIG Eases COPD Symptoms in Rat Model

An anti-inflammatory compound used in China to help treat liver disease — known as magnesium isoglycyrrhizinate (MgIG) — eased the symptoms of chronic obstructive pulmonary disease (COPD) by reducing inflammation in the lungs, a study in a rat disease model reported. “These findings suggest MgIG might be an alternative for COPD therapy,” its scientists wrote. The study, “Magnesium isoglycyrrhizinate inhibits airway inflammation in rats with chronic obstructive pulmonary disease,” was published in the journal BMC Pulmonary…

You must be logged in to read/download the full post.